Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
1.150
-0.140 (-10.85%)
Apr 8, 2026, 2:31 PM EDT - Market open
Onconetix Market Cap
Onconetix has a market cap or net worth of $796.87 thousand as of April 8, 2026. Its market cap has decreased by -57.20% in one year.
Market Cap
796.87K
Enterprise Value
-4.28M
1-Year Change
-57.20%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since the IPO on February 18, 2022, Onconetix's market cap has decreased from $633.29M to $796.87K, a decrease of -99.87%. That is a compound annual growth rate of -80.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 893.88K | -63.15% |
| Dec 31, 2025 | 2.43M | -53.58% |
| Dec 31, 2024 | 5.23M | 43.62% |
| Dec 29, 2023 | 3.64M | -78.62% |
| Dec 30, 2022 | 17.02M | -97.31% |
| Feb 18, 2022 | 633.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oragenics | 2.61M |
| Adial Pharmaceuticals | 2.51M |
| Propanc Biopharma | 2.48M |
| Clearmind Medicine | 2.28M |
| Bone Biologics | 2.19M |
| Scinai Immunotherapeutics | 2.15M |
| SciSparc | 2.04M |
| CNS Pharmaceuticals | 1.83M |